JPMorgan Chase & Co. Sells 119,903 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

JPMorgan Chase & Co. decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 15.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 659,274 shares of the medical instruments supplier’s stock after selling 119,903 shares during the quarter. JPMorgan Chase & Co. owned 2.69% of ICU Medical worth $120,133,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP grew its position in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after acquiring an additional 100 shares during the last quarter. Xponance Inc. boosted its position in ICU Medical by 6.0% during the 2nd quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock valued at $235,000 after buying an additional 112 shares during the period. Equitable Trust Co. grew its holdings in ICU Medical by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock worth $950,000 after acquiring an additional 112 shares during the last quarter. Hexagon Capital Partners LLC raised its stake in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after acquiring an additional 122 shares during the last quarter. Finally, Connable Office Inc. raised its stake in shares of ICU Medical by 6.4% during the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier’s stock valued at $370,000 after acquiring an additional 122 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on ICUI shares. KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Raymond James raised their price target on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Finally, StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $199.67.

Insiders Place Their Bets

In other ICU Medical news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director David C. Greenberg sold 972 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total transaction of $153,682.92. Following the sale, the director now owns 5,037 shares in the company, valued at approximately $796,400.07. The trade was a 16.18 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,364 shares of company stock worth $4,728,358. 6.70% of the stock is currently owned by company insiders.

ICU Medical Stock Performance

Shares of ICU Medical stock opened at $155.17 on Thursday. The business has a fifty day simple moving average of $164.91 and a two-hundred day simple moving average of $155.49. The firm has a market capitalization of $3.80 billion, a P/E ratio of -33.95 and a beta of 0.62. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12 month low of $86.80 and a 12 month high of $196.26.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.